Remove Drug Development Remove Research Laboratories Remove Vaccines
article thumbnail

Pharmaceutical microbiology: key developments 2022

European Pharmaceutical Review

The safety and efficacy of mRNA vaccines should be a game changer and is the likely solution to antibiotic-resistant microorganisms and emerging viral pathogens.” The previous record for vaccine development and approval was four years for the measles vaccine.

Vaccines 128
article thumbnail

European Pharmaceutical Review Issue 3 2024

European Pharmaceutical Review

The post <em>European Pharmaceutical Review </em> Issue 3 2024 appeared first on European Pharmaceutical Review.

article thumbnail

Cerba Research and Teddy Lab sign Memorandum of Understanding on entering into a discussion for Joint Venture

Pharmaceutical Technology

The formal signing ceremony of the MoU today at Cerba Research’s Ghent office was led by Mario Papillon, CEO of Cerba Research, and Xu Yi, CEO of Teddy Lab, on behalf of their respective organisations. About Teddy Clinical Research Laboratory : As a joint venture company established in 2016 by Dian Diagnostics (300244.SZ)